Neuropore Therapies was awarded a $500,000 grant from The ALS Association to advance in preclinical work its neural protective…
Articles by Catarina Silva
Bloom Science and Duke University have entered into an exclusive licensing agreement that provides the biopharmaceutical company access…
AI Therapeutics‘ lymphoma candidate LAM-002 was identified by the company’s artificial intelligence-based platform — called Guardian…
Stealth BioTherapeutics announced the initiation of a Phase 1 trial to assess the safety and tolerability of its investigational oral…
A first patient has been dosed in a Phase 2 trial testing a nanomedicine called CNM-Au8 as a potentially disease-modifying therapy…
A recently completed Phase 1 trial studying NPT520-34 — an investigational small molecule being developed by Neuropore Therapies…
A compound found in rice bran oil may lower oxidative stress levels and may be beneficial to people with amyotrophic…
The most common genetic cause of amyotrophic lateral sclerosis (ALS) disrupts the shape and workings of a compartment inside…
People with mutations in the gene coding for tumor protein p73 (TP73) are at higher risk of developing amyotrophic…
High LDL cholesterol levels, also known as “bad cholesterol,” may contribute to the development of amyotrophic lateral sclerosis (ALS),…